Accordingly, low H3K18ac levels in BC patients are associated with high tumor grade; conversely, high levels are positively correlated with hormone receptor, E-cadherin, and BRCA1 expression, negatively correlated with p53 and HER2 expression, and associated with a more favorable prognosis [113]. This evidence concerns the gene ERBB2 and neoplasm.